Affymax, Inc. Sets Terms For 3.5 Million Share IPO

WASHINGTON, Nov 30 (Reuters) - Biopharmaceutical company Affymax Inc. filed with the U.S. Securities and Exchange Commission on Thursday to sell up to 3.5 million shares for between $22 and $24 per share in an initial public offering of stock.

>>> Discuss This Story